Physician Wealth Advisors’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$592 Hold
35
– – ﹤0.01% 2153
2026
Q2
$510 Buy
+35
New +$621 ﹤0.01% 2118
2026
Q1
– Sell
-55
Closed -$962 – 2218
2025
Q4
$962 Hold
55
– – ﹤0.01% 1649
2025
Q3
$1.14K Hold
55
– – ﹤0.01% 1503
2025
Q2
$1.17K Buy
+55
New +$1.25K ﹤0.01% 1290

Other funds holding SMMT

Physician Wealth Advisors's SMMT Position: Q3 2026 in Review

Physician Wealth Advisors held its Summit Therapeutics (SMMT) position steady in Q3 2026 at 35 shares worth $592. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

Physician Wealth Advisors first reported a position in SMMT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.17K in Q2 2025. 294 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Physician Wealth Advisors held 35 shares of Summit Therapeutics worth $592 as of Q3 2026.
  • Physician Wealth Advisors left its Summit Therapeutics share count unchanged in Q3 2026.
  • Summit Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2153 holding.
  • Physician Wealth Advisors first reported a position in Summit Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Physician Wealth Advisors's Summit Therapeutics position peaked at $1.17K in Q2 2025.
  • 294 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.